Mettler-Toledo International, Inc. Common Stock (MTD)
1,257.84
0.00 (0.00%)
Mettler-Toledo International is a global leader in precision instruments and weighing systems, providing innovative solutions to a wide range of industries including food, pharmaceuticals, and laboratories
The company specializes in high-quality analytical and measuring instruments, which facilitate accurate measurements in various applications, from manufacturing processes to scientific research. Mettler-Toledo is committed to enhancing productivity, ensuring compliance with regulatory standards, and achieving exceptional measurement accuracy, thereby supporting its customers in optimizing their operations and improving overall efficiency. The company also offers comprehensive services, including calibration and maintenance, ensuring that its clients receive optimal performance from their equipment.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Thermo Fisher (NYSETMO) and its peers.
Life sciences tools company Agilent Technologies (NYSEA)
will be announcing earnings results tomorrow after market close. Here’s what you need to know.
Over the past six months, Mettler-Toledo’s shares (currently trading at $1,304) have posted a disappointing 8.9% loss, well below the S&P 500’s 8.9% gain. This may have investors wondering how to approach the situation.
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights.
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.
Precision measurement company Mettler-Toledo (NYSEMTD) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 11.8% year on year to $1.05 billion. Its non-GAAP profit of $12.41 per share was 5.8% above analysts’ consensus estimates.
It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged up 0.3%, while the Dow Jones slipped 0.1% and small caps held steady.
A worse-than-expected University of Michigan’s May consumer report halted stock gains on Friday, sparking worries about a potential decline in consumer health amid perceived rising price pressures.
